1. Xie, S, Li, M, Jiang, F, Yi, Q, Yang, W. . [EHHADH is a key gene in fatty acid metabolism pathways in hepatocellular carcinoma: a transcriptomic analysis]. In Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 43, 680-693. doi:10.12122/j.issn.1673-4254.2023.05.02. https://pubmed.ncbi.nlm.nih.gov/37313808/
2. Cui, Juncheng, Yi, Guoliang, Li, Jinxin, Li, Yangtao, Qian, Dongyang. 2021. Increased EHHADH Expression Predicting Poor Survival of Osteosarcoma by Integrating Weighted Gene Coexpression Network Analysis and Experimental Validation. In BioMed research international, 2021, 9917060. doi:10.1155/2021/9917060. https://pubmed.ncbi.nlm.nih.gov/33997049/
3. Pilz, Julia Felicitas, Klein, Marinella, Neumann-Haefelin, Elke, Ganner, Athina. 2024. VHL-dependence of EHHADH Expression in a Human Renal Cell Carcinoma Cell Line. In Journal of kidney cancer and VHL, 11, 12-18. doi:10.15586/jkcvhl.v11i1.322. https://pubmed.ncbi.nlm.nih.gov/38304003/
4. Klootwijk, Enriko D, Reichold, Markus, Helip-Wooley, Amanda, Warth, Richard, Kleta, Robert. . Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome. In The New England journal of medicine, 370, 129-38. doi:10.1056/NEJMoa1307581. https://pubmed.ncbi.nlm.nih.gov/24401050/
5. Houten, Sander M, Denis, Simone, Argmann, Carmen A, Reddy, Janardan K, Wanders, Ronald J A. 2012. Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids. In Journal of lipid research, 53, 1296-303. doi:10.1194/jlr.M024463. https://pubmed.ncbi.nlm.nih.gov/22534643/
智鼠故事 
